NCT07115043 2026-03-17
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
AstraZeneca
Phase 1/2 Recruiting
AstraZeneca
Neonc Technologies, Inc.
Bruce Robinson, MD
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello